The Vision Care Institute launches UV app

Article

Eyecare professionals have a new tool to help them educate patients about UV exposure, courtesy of The Vision Care Institute.

Jacksonville, FL-Eyecare professionals have a new tool to help them educate patients about UV exposure, courtesy of The Vision Care Institute.

Both eyecare practitioners and their staffs can use this tool during examinations and follow-up visits to help patients better understand the risks of sun exposure and how to better protect themselves.

The Vision Care Institute UV Protection App  can demonstrate:

• Who needs UV protection

• Cumulative ocular effects of UV

• Impact of environmental ocular exposure

• Preventative measures for UV protection

The app is free and designed specifically for iPad usage. Download it via the Apple App store.

“It is important we educate patients about the simple methods they should use to help protect their eyes and the eyes of their families all year-round,” says Sheila Hickson-Curran, BSc(Hons), MCOptom, FAAO, DipCCLR,  director, global strategic medical affairs, Johnson & Johnson Vision Care, Inc. “This new app can be a valuable teaching tool for practitioners to help patients understand why protecting their eyes is as important as protecting their skin.”

According to the company, the app is not intended as, and does not constitute medical or optometric advice. It is available only in the U.S. App Store at this time.

The Vision Care Institute is part of the Johnson & Johnson Family of Companies, which also includes Johnson & Johnson Vision Care, Inc.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.